Baxter International | BAX - Ebitda

Aktienkurs
17.30
Täglich Wechseln
-0.48 -2.70%
Monatlich
-4.63%
Jährlich
-45.36%
Q2 Prognose
16.95




Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
AngioDynamics USD 5.94M 3.78M 2025-09
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 17.07M 2.79M 2026-03
Avanos Medical USD 13M 3M 2025-12
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Fresenius EUR 951M 283M 2026-03
Globus Medical USD 280.46M 27.86M 2025-12
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
ICU Medical USD 98.68M 489K 2026-03
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Laboratory Of America USD 605.6M 17.5M 2026-03
Masimo USD 85.5M 6.4M 2026-03
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 247.07M 575.88M 2025-12
Terumo JPY 57.88B 12.1B 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12